Mercer Global Advisors Inc Bridge Bio Pharma, Inc. Transaction History

Mercer Global Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$23.0 - $31.04 $1,679 - $2,265	-73 Reduced 0.51%	14,198 $359,000
Q1 2024 May 15, 2024	BUY	$27.35 - $40.45 $2,707 - $4,004	99 Added 0.7%	14,271 $441,000
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $1,417 - $2,589	59 Added 0.42%	14,172 $572,000
Q2 2023 Aug 14, 2023	BUY	$13.29 - $18.01 $48,016 - $65,070	3,613 Added 34.41%	14,113 $242,000
Q1 2023 May 15, 2023	SELL	$7.17 - $18.55 $279 - $723	-39 Reduced 0.37%	10,500 $174,000
Q3 2022 Nov 15, 2022	BUY	$7.94 - $12.36 $83,679 - $130,262	10,539 New	10,539 $105,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.47B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Mercer Global Advisors Inc with notifications on news.